Cargando…
Targeting dePARylation for cancer therapy
Poly(ADP-ribosyl)ation (PARylation) mediated by poly ADP-ribose polymerases (PARPs) plays a key role in DNA damage repair. Suppression of PARylation by PARP inhibitors impairs DNA damage repair and induces apoptosis of tumor cells with repair defects. Thus, PARP inhibitors have been approved by the...
Autores principales: | Kassab, Muzaffer Ahmad, Yu, Lily L., Yu, Xiaochun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988220/ https://www.ncbi.nlm.nih.gov/pubmed/32010441 http://dx.doi.org/10.1186/s13578-020-0375-y |
Ejemplares similares
-
Targeting dePARylation selectively suppresses DNA repair–defective and PARP inhibitor–resistant malignancies
por: Chen, Shih-Hsun, et al.
Publicado: (2019) -
DePARylation is critical for S phase progression and cell survival
por: Nie, Litong, et al.
Publicado: (2023) -
Functions of PARylation in DNA Damage Repair Pathways
por: Wei, Huiting, et al.
Publicado: (2016) -
Coupling bimolecular PARylation biosensors with genetic screens to identify PARylation targets
por: Krastev, Dragomir B., et al.
Publicado: (2018) -
PARP Inhibitors as Therapeutics: Beyond Modulation of PARylation
por: Min, Ahrum, et al.
Publicado: (2020)